Primary care and urology patients with the male pelvic pain syndrome: Symptoms and quality of life

University of Washington Seattle, Seattle, Washington, United States
The Journal of Urology (Impact Factor: 3.75). 05/2002; 167(4):1768-73. DOI: 10.1016/S0022-5347(05)65196-8
Source: PubMed

ABSTRACT We assessed symptoms and health related quality of life in men who received prostatitis-prostatodynia diagnoses at primary care and urology visits, and compared those in whom pain-discomfort had versus had not resolved approximately 1 month later.
Telephone interviews were done with 357 men an average of 1 month after a prostatitis-prostatodynia diagnosis was made at a health maintenance organization visit. The interview included the National Institutes of Health Chronic Prostatitis Symptom Index, and pain and health related quality of life measures.
The most common pain location was the pubic-bladder area. Mean scores on most health related quality of life measures were below average, and higher pelvic pain and urinary symptom scores were associated with worse quality of life. This episode of pelvic pain was the first lifetime episode in fewer urology (22%) than primary care (38%) patients (p = 0.02). Urology patients had longer symptom episodes (p = 0.000), more days with pain in the last month (p = 0.002) and higher National Institutes of Health Chronic Prostatitis Symptom Index pain scores (p = 0.002). Men with pain in the testicles, penis or between the rectum and testicles at the visit, and with longer symptom duration before the visit were significantly more likely to have continued pain between the visit and interview.
Pelvic pain is often a persistent, recurrent condition that can have a significant negative impact on quality of life. The average symptom severity in men with pelvic pain in primary care and urology settings is lower than that in tertiary care samples.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives. To investigate the effectiveness of extracorporeal shock wave therapy (ESWT) for symptoms alleviation in chronic pelvic pain syndrome (CPPS). Materials and Methods. 40 patients with CPPS were randomly allocated into either the treatment or sham group. In the first group, patients were treated by ESWT once a week for 4 weeks by a defined protocol. In the sham group, the same protocol was applied but with the probe being turned off. The follow-up assessments were done at 1, 2, 3, and 12 weeks by Visual Analogue Scale (VAS) for pain and NIH-developed Chronic Prostatitis Symptom Index (NIH-CPSI). Results. Pain domain scores at follow-up points in both treatment and sham groups were reduced, more so in the treatment group, which were significant at weeks 2, 3, and 12. Urinary scores became significantly different at weeks 3 and 12. Also, quality of life (QOL) and total NIH-CPSI scores at all four follow-up time points reduced more significantly in the treatment group as compared to the sham group. Noticeably, at week 12 a slight deterioration in all variables was observed compared to the first 3 weeks of the treatment period. Conclusions. our findings confirmed ESWT therapy as a safe and effective method in CPPS in short term.
    08/2013; 2013:972601. DOI:10.1155/2013/972601
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) is a chronic pain disease with high prevalence rates and substantial health care costs. An interdisciplinary classification system is commonly used (UPOINT) which includes psychosocial factors. Nevertheless, psychosocial influences on CP/CPPS only recently became a research focus. Therefore, we aimed to synthesize the existing data and to identify further research topics. Then, based on our results, diagnosis and treatment can be improved.
    Journal of Psychosomatic Research 09/2014; 77(5). DOI:10.1016/j.jpsychores.2014.09.012 · 2.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) are today among the most frequent and most disturbing chronic diseases in terms of sexuality. In men with micturition disorders related to BPH, there is a four times greater risk of sexual dysfunction, either erectile or orgasmic. As LUTS disorders and the related embarrassment take hold, a large part of the patient's lifestyle gradually shrinks, leading to a perceptible reduction in quality of life and the sexual, relational, and psychological aspects of life in men who are affected, as well as disruption of mood that can result in serious anxiety and depressive disorders. These disorders are often underestimated by the medical profession and remain undisclosed by patients, often convinced of the lack of therapeutic solutions. Treatment provides rapid improvement in sexual function as well as in mood and urinary function.
    Sexologies 04/2014; 23(2):85–90. DOI:10.1016/j.sexol.2014.04.004